0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch 2017 2022 lenalidomide report global united states market status forecast players.Your search for "" gave back 1533064 results.
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Summary Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
February 2023
Price: USD 2,960.00
Summary Publisher Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
May 2021
Price: USD 2,960.00
Summary Lenalidomide market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
July 2020
Price: USD 2,960.00
Summary The global Lenalidomide market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and...
Catalog:
HYR
February 2022
Price: USD 1,800.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The “Immunomodulator for Multiple Myeloma Industry Forecast” looks at past sales and reviews total world Immunomodulator for Multiple Myeloma sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Immunomodulator for Multiple Myeloma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
REVLIMID® (lenalidomide), an immunomodulatory therapy used to treat people with multiple myeloma According to our Publisher latest study, the global...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
